Request Sample

Global Sarcoma Biopsy Market

June 3, 2019

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR635      
Pages :190 Pages
Format :   PPT Format   PDF Format

The global sarcoma biopsy market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Sarcoma is basically known as cancer of soft tissue whereas; biopsy is a process of withdrawing of a minor amount of tissue for observation under a microscope. Imaging tests may recommend the detection of sarcoma, but biopsy is executed to validate the diagnosis and to discover the type of sarcoma. Several kinds of biopsies are being conducted to detect sarcomas and most of the biopsies are needle biopsies, in which needle is used to retrieve the skeptical tissue of sarcoma.

Table 1. Global Sarcoma Biopsy Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product Type)

Reusable Device, Disposable Devices

Market Segmentation (By End User)

Hospitals, Ambulatory Surgical Centers, Diagnostic Centers

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

 Becton, Dickinson and Company, C. R. Bard, Inc., Argon Medical Devices, Cook Medical Incorporated, InVivo Therapeutics Corporation, UROMED, and Sterylab, among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The global sarcoma biopsy market is estimated to grow evidently over the forecast period, owing to soaring governing approval for biopsy instruments. For instance, in 2018, TransMed7, LLC got the U.S. FDA 510(k) approval for its SpeedBird platform of soft tissue biopsy instruments. The SpeedBird platform is hinged on TransMed7’s patented Zero5TM work substance composed of a fused, solo element manufactured from 3 hypotubes and builds circulating twin cutter blades. Moreover, rising prevalence of osteosarcoma is anticipated to steer the sarcoma biopsy market growth in the upcoming future. For instance, as per the American Cancer Society, 2020, approximately 800 to 900 new cases of osteosarcoma are being reported in the US every year, with nearby half of these arise in toddlers and teenagers. As per the report of American Cancer Society gauges, the occurrences of synovial sarcoma in the U.S. in the year 2018 was estimated to be 13,040 patients out of which 7,370 found in males and 5,670 in females.

Technologically forged biopsy guidance systems namely vacuum abated guns are capturing popularity amongst patients and healthcare assisters. Additionally, growing prevalence of cancer is further predicted to strengthen the growth of the market. However, the high cost involved in sarcoma surgeries and diagnosis acts as a restraint for the growth of the market.

Figure 1. PORTER’S Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is deemed to hold the highest market share in the sarcoma biopsy market owing to increasing healthcare investment in the U.S. For instance, in 2017, in the U.S., as per the Committee of Responsible Federal Budget, declared around US$ 3.5 trillion,  or 18% of the aggregate GDP, on health lavishing, which is surpassingly twice the average among developed nations. The Sarcoma Foundation of America (SFA) is a key body that is been unrolling consciousness regarding sarcoma which covers various population groups. The foundation recently declared that it would invest fresh funds for research regarding sarcoma. The finance is a part of the 2020 SFA Research Grant program. This organization focuses to expand a total of 15 research permits, per head worth $50,000 for several researchers. The research funding shall archly impact the growth of sarcoma biopsy market in this region.

Besides, Asia Pacific is also estimated to show remarkable surge in the global sarcoma biopsy market, owing to rising healthcare amenities. For instance, in 2015, as per the India Brand Equity Foundation, approximately 156,926 sub centers[2] , and 196,312 hospitals are established in India.

Figure 2. Regional Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in the global sarcoma biopsy market market include: Becton, Dickinson and Company, C. R. Bard, Inc., Argon Medical Devices, Cook Medical Incorporated, InVivo Therapeutics Corporation, UROMED, and Sterylab, among others.

Market players have planned various strategies to survive and boost their revenue in the market as many of them adopted new product launches, investment on R&D and huge investment on advance technologies. For instance, in September, 2014, Argon Medical Devices, Inc. declared that it has acquired Promex Technologies, LLC, a producer and supplier of soft-tissue biopsy products as well as the TLAB Transjugular Liver Biopsy Instrument ("TLAB"). The acquisition signifies Argon Medical as one of two organizations participating in the transjugular liver biopsy market and accomplishing its line of soft-tissue biopsy devices. With the amalgamation of TLAB, Argon Medical now furnishes instruments to collect liver samples using either percutaneous or transjugular access methods.

Table 3. Market Share of Key Players, 2019

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Product Type

  • Reusable Device
  • Disposable Devices

 By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global sarcoma biopsy market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global sarcoma biopsy market?
  • What key factors are expected to increase the demand for sarcoma biopsy market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global sarcoma biopsy market?
  • What is the total market value (US$ Mn) generated in global sarcoma biopsy market by product type in 2019 and what are the forecasts by 2025?
  • Which end user is expected to dominate the sarcoma biopsy market in the coming years?
  • What was the total revenue generated by the global sarcoma biopsy market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global sarcoma biopsy market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the sarcoma biopsy market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.